"Disordered proliferative endometrium" is a somewhat vague term that generally indicates the unusual growth of endometrial cells. The term can refer to a form of simple endometrial hyperplasia — or the abnormal thickening of the endometrial lining — but it can indicate a more serious problem in some cases.
Proliferative endometrium stage The term “proliferative” means that cells are multiplying and spreading. During this phase, your estrogen levels rise. This causes your endometrium to thicken. Your ovaries also prepare an egg for release. This phase lasts for half your cycle, usually 14 to 18 days.
621.33 - Endometrial hyperplasia with atypia. ICD-10-CM.
N85. 00 - Endometrial hyperplasia, unspecified | ICD-10-CM.
The most common treatment is progestin. This can be taken in several forms, including pill, shot, vaginal cream, or intrauterine device. Atypical types of endometrial hyperplasia, especially complex, increase your risk of getting cancer. If you have these types, you might consider a hysterectomy.
Disordered proliferative endometrium is common in the perimenopausal years because of anovulatory cycles. In any case, the management of simple endometrial hyperplasia and disordered proliferative endometrium is usually identical, in the form of progestogenic compounds.
621.31 - Simple endometrial hyperplasia without atypia | ICD-10-CM.
Endometrial hyperplasia is an abnormal proliferation of the uterine endometrial glands due to effects of estrogen unopposed by progesterone. This condition can be benign or represent a precancerous endometrial lesion.
The 2022 edition of ICD-10-CM N85. 02 became effective on October 1, 2021. This is the American ICD-10-CM version of N85.
ICD-10 code R93. 89 for Abnormal findings on diagnostic imaging of other specified body structures is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
ICD-10 code: N93. 9 Abnormal uterine and vaginal bleeding, unspecified.
Significant endometrial pathology was defined as endometrial hyperplasia with or without atypia and endometrial carcinoma, while benign diseases were proliferative, secretory, atrophic, basal endometrium, endometrial polyp, and inflammatory conditions.